Evaluationofthe combination ofmetforminand rapamycinin an mpp -treated sh-sy5y model of parkinson’s disease

HIGHLIGHTS

  • who: Chureerat Norradee and colleagues from the Department of Anatomy, Faculty of Science, Mahidol University, Bangkok have published the research work: Evaluationofthe Combination ofMetforminand Rapamycinin an MPP -Treated SH-SY5Y Model of Parkinsonu2019s Disease, in the Journal: Advances in Pharmacological and Pharmaceutical Sciences of 16/01/2023
  • how: Te results showed that MET and RAPA combinations lowered cell viability after exposure to MPP+. For multiple comparisons data were analyzed using a one-way analysis of variance (ANOVA) followed by a posthoc analysis (Tukey`s multiple comparison test) using GraphPad Prism 5 software. Te results showed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?